| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Hims & Hers Health, Inc. (NYSE:HIMS) reported its second-quarter financial results Monday. Here's a look at the details from the report.
The Details: Hims & Hers Health reported quarterly earnings of 6 cents per share which beat the analyst consensus estimate of 3 cents.
Quarterly sales clocked in at $315.648 million, which beat the analyst consensus estimate by 5.24% and represents a 51.82% increase over sales of $207.912 million from the same period last year.
Gross margin was 81% and free cash flow was $47.6 million for the second quarter of 2024 compared to $10 million from the second quarter of 2023.
“Our second quarter results mark an acceleration in what was already an incredible trajectory. During the quarter, subscribers on our platform approached 1.9 million, increasing 43% year-over-year,” said Andrew Dudum, co-founder and CEO.
“We believe access to life-changing solutions should be simple, convenient, affordable, and designed for the individual. As we expand the capabilities on our platform, we are only more convinced that we can help an individual in every household in the country feel great.”
Read Also: What’s Going On With SoFi Stock After Earnings?
Outlook: Hims & Hers expects third-quarter revenue in a range of $375 million to $380 million and full-year revenue of $1.37 billion to $1.4 billion.
HIMS Price Action: According to Benzinga Pro, Hims & Hers Health shares are down 10.59% after-hours at $15.95 at the time of publication Monday.
Read Next:
Image: Courtesy of Hims& Hers Health, Inc.
Posted In: HIMS
